@wired.com 8 months ago
Squids' Gene-Editing Superpowers May Unlock Human Cures
@xconomy.com 10 months ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com 11 months ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com 1 year ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com 2 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com 2 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com 2 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com 2 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com 2 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com 2 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
@xconomy.com 2 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”
@extremetech.com 4 years ago
Scientists find abandoned drug effective against two human viruses
@extremetech.com 4 years ago
Triple-helix RNA cancer treatment from MIT shows major promise
@WIRED 5 years ago
Cofactor is an RNA sequencing company that's turning away from drug discovery for big pharma toward consumer diagnostics.
@theverge.com 5 years ago
Sequencing the RNA of sperm may better diagnose a man's infertility